HIKMA PHARMACEUTIC.LS-,10
HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
H5P
11/06/2024 21:49:59
|
Chg.
+0.6000
|
Volume |
Bid21:50:01 |
Ask21:50:01 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
23.6000EUR
|
+2.61%
|
0 Turnover: 0.0000 |
-Bid Size: - |
-Ask Size: - |
5.16 bill.EUR |
- |
- |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
0.86 USD |
2.50% |
EPS Diluted: |
- USD |
1.67% |
Revenues per Share: |
13.00 USD |
20.42% |
Book Value per Share: |
9.94 USD |
8.53% |
Cash Flow per Share: |
2.75 USD |
20.94% |
Dividend per Share: |
0.72 USD |
28.57% |
Total |
in mill. |
|
Revenues: |
2,875.00 USD |
14.22% |
Net Income: |
190.00 USD |
1.06% |
Operating Cash Flow: |
608.00 USD |
- |
Cash and Cash Equivalents: |
205.00 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
29.20 |
26.51 |
P/S Ratio: |
1.93 |
1.75 |
P/BV ratio: |
2.53 |
2.29 |
P/CF Ratio: |
9.13 |
8.29 |
PEG: |
11.67 |
10.59 |
Earnings Yield: |
3.42% |
3.77% |
Dividend Yield: |
2.87% |
3.16% |
Market Capitalization |
|
Market Capitalization: |
5.16 bill. EUR |
4.57 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
- EUR |
- EUR |
Shares Outstanding: |
221.08 mill. |
|
Profitability
Gross Profit Margin: |
48.35% |
EBIT Margin: |
12.77% |
Net Profit Margin: |
6.61% |
Return on Equity: |
8.64% |
Return on Assets: |
4.06% |
Financial Strength
Liquidity I / Cash Ratio: |
15.31% |
Liquidity II / Quick Ratio: |
76.85% |
Liquidity III / Current Ratio: |
156.83% |
Debt / Equity Ratio: |
112.92% |
Dynam. Debt / Equity Ratio: |
408.22% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
31/12/2023 |
Accounting Standard: |
IFRS |